Literature DB >> 21937840

[Dosimetric perturbation due to scattered rays released by a gold marker used for tumor tracking in external radiotherapy].

Kosaku Habara1, Tomohiro Shimozato, Yuichi Aoyama, Naoki Hayashi, Keisuke Yasui, Kanji Matsuura, Takashi Furukawa, Ryota Kawanami, Yasunori Obata.   

Abstract

Image-guided radiation therapy using a gold marker-based tumor tracking technique provides precise patient setup and monitoring. However, the marker consists of high-Z material, and the resulting scattered rays tend to have adverse effects on the dose distribution of radiotherapy. The purpose of this study was to evaluate the dosimetric perturbation due to the use of a gold marker for radiotherapy in the lungs. The relative dose distributions were compared with film measurement, Monte Carlo simulation, and XiO calculation with the multi grid superposition algorithm using two types of virtual lung phantoms, which were composed of tough water phantoms, tough lung phantoms, cork boards, and a 2.0-mm-diameter gold ball. No dose increase and decrease in the vicinity of the gold ball was seen in the XiO calculations, although it was seen in the film measurements and the Monte Carlo simulation. The dose perturbation due to a gold marker cannot be evaluated using XiO calculation with the superposition algorithm when the tumor is near a gold marker (especially within 0.5 cm). To rule out the presence of such dose perturbations due to a gold marker, the distance between the gold marker and the tumor must therefore be greater than 0.5 cm.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937840     DOI: 10.6009/jjrt.67.1164

Source DB:  PubMed          Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi        ISSN: 0369-4305


  1 in total

1.  Systematic survey of the dose enhancement in tissue-equivalent materials facing medium- and high-Z backscatterers exposed to X-rays with energies from 5 to 250 keV.

Authors:  M Seidenbusch; D Harder; D Regulla
Journal:  Radiat Environ Biophys       Date:  2014-03-15       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.